20200316-麦肯锡咨询-COVID-19__Briefing_Note_34页_1mb

Summary of McKinsey & Company's COVID-19 Briefing Note

Core Content

This document provides an overview of the global impact of the COVID-19 pandemic and outlines key actions for companies to prepare and respond effectively. It emphasizes the importance of a centralized Crisis Nerve Center to manage the crisis and highlights the epidemiological and economic scenarios that could unfold.

Main Points

1. The Situation Now

• Global spread: The virus is spreading rapidly in Europe and the Middle East, while Asia (particularly China and South Korea) has seen a decline in cases.
• United States: Although initial case numbers are low, the situation is expected to worsen once widespread testing becomes available.
• Severity: The disease is more dangerous than the flu, with a case fatality rate (CFR) of up to 20% in severe/critical cases, and ~3.4% globally, depending on factors like age, health system capacity, and comorbidities.
• Age impact: Individuals 50+ make up 40–76% of confirmed cases, with higher fatality rates among older populations.

2. Possible Future Scenarios

a. Delayed Recovery

• Cases in the Middle East, Europe, and US are expected to rise through mid-April 2020, with a decline by June due to public health measures and seasonality.
• Fall 2020 may see a resurgence, but warmer climates and younger demographics in parts of South and Southeast Asia, Africa, and Latin America may reduce the impact.
• China and East Asia are expected to control the virus by late Q1 or early Q2 2020, but supply chains may remain impaired.

b. Prolonged Contraction

• The virus may spread globally without seasonal decline, leading to a demand shock that lasts until Q2 2021.
• Health systems in poorer countries may be overwhelmed, with large-scale human and economic impacts.
• China and East Asia may face double-dip slowdowns, with recovery pushed to Q1 2021.
• US and Europe may experience deep recessions in 2020, with GDP contraction and slow recovery starting in Q2 2021.

3. Actions for Companies to Consider

• Establish a Crisis Nerve Center: A cross-functional team to coordinate efforts in protecting employees, managing supply chains, engaging customers, and stress-testing financials.
• Workforce protection: Develop policies aligned with public health guidance, provide remote working infrastructure, and ensure safety measures are in place.
• Supply chain stabilization: Create transparency across tiers, assess interruption risks, optimize production and logistics, and engage suppliers and customers.
• Customer engagement: Provide transparency, protection, and outreach to customers, especially in B2B contexts.
• Financial stress testing: Evaluate different scenarios and working capital requirements to prepare for economic impacts.

Key Information

• Confirmed cases: Over 153,000 as of March 15, 2020, with >5,700 deaths.
• Countries affected: Over 140 countries have reported cases, with >80 showing local transmission.
• Transmission complexes: The virus is concentrated in five major regions, including China, South Korea, Italy, the US, and the Middle East.
• Economic impact: Global GDP growth is expected to fall sharply in 2020, with recessions in the US and Europe and slower growth in China and other Asian countries.

Leading Indicator Dashboards

• Companies should use dashboards to monitor leading indicators and track the evolution of the situation.
• These dashboards help in scenario planning, risk assessment, and decision-making.

Crisis Nerve Center Structure

• 5 Teams, 18 Workstreams:
  • Team A: Workforce protection (policies, communication, remote work, workplace norms, health and government engagement)
  • Team B: Supply chain stabilization (supplier engagement, inventory management, production, demand, logistics)
  • Team C: Customer engagement (B2B transparency, customer protection, outreach)
  • Team D: Financial stress testing (scenario definition, financial modeling)
  • Team E: Operating the nerve center (issue management, action portfolio, leadership alignment)

Official Health Sources

• WHO: Provides situation reports, guidance, and case fatality data.
• CDC: Offers prevention guidance, business response tools, and industry-specific recommendations.
• Local health authorities: Should be consulted for tailored policies and regulatory compliance.

Conclusion

The pandemic presents a global humanitarian challenge and a complex crisis requiring swift and coordinated action. Companies must prepare for multiple scenarios, protect their workforce, stabilize supply chains, and engage customers effectively. A Crisis Nerve Center is essential for managing the response and ensuring business continuity.